Last reviewed · How we verify
NCT03712215
STUDY OF ELECTRICAL STIMULATION IN PULMONARY FUNCTION IN INTENSIVE CARE UNIT
NA trial testing Rehabilitation in Respiratory Distress Syndrome, Adult in 30 participants. Completed in 31 January 2019.
31 January 2019
Quick facts
| Lead sponsor | Universidade Metodista de Piracicaba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 4 September 2018 |
| Primary completion | 31 January 2019 |
| Estimated completion | 31 January 2019 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Rehabilitation
Conditions studied
- Respiratory Distress Syndrome, Adult — all drugs for Respiratory Distress Syndrome, Adult →
Sponsor
Universidade Metodista de Piracicaba
Who can join
Adults 60 to 80, any sex, with Respiratory Distress Syndrome, Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: The Mechanical Ventilation (MV), a support method used in Intensive Care Units (ICU), reaches approximately 90% of critical patients whose withdrawal process represents 40% of the total time of their use. For this purpose Transcutaneous electrical diaphragmatic stimulation (TEDS), which by means of electrodes placed in motor action points on the phrenic nerve tend to provide improvement of the diaphragm muscle function. Objective: To analyze the effect of two protocols of transcutaneous electrical diaphragmatic stimulation on the ventilatory and cardiorespiratory parameters of critically ill patients. Method: Clinical, longitudinal, prospective, quantitative, single center trial will be performed with 30 (thirty) participants in invasive mechanical ventilatory support, randomly divided into three groups: Experimental Group 1 (GE-1; n = 10) where they will be submitted to the TEDS protocol; Experimental Group 2 (GE-2; n = 10), where they will be submitted to the TEDS protocol based on the studies of Cancelliero et al. (2012); Control Group (GC; n = 10) where they will not be submitted to TEDS. All groups will receive physiotherapeutic care from the staff of the adult ICU of the FHCGV. The interventions will consist of ten sessions of Physical Therapy in each participant in the afternoon shift, for ten consecutive days, 1 time a day. For the TEDS procedure, the Orion TENS II (Orion-SP-Brazil) model will be used, the Wright analogue respirometer (Spire-SP-Brazil) will be used for the minute volume evaluation (V'). The variables of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and peripheral oxygen saturation (SpO2) will also be monitored in order to verify if the TEDS application interferes with the hemodynamic variables of these patients. The data collected will be linked to Microsoft Office Excel® 2010 software and later transformed into tables and graphs. The information collected will be submitted to statistical analysis through the statistical package SPSS 22.0, applying the descriptive statistics for the characterization of the sample and then selecting the specific tests for the respective variances, adopting a level of significance of p≤0.05 for statistical inferences.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03712215
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Rehabilitation
Trials testing the same drug.
- NCT07320222 — CARE-Melanoma Trial · Phase 1 · not yet recruiting
- NCT06926699 — MPFL Reconstruction Versus Rehabilitation · NA · not yet recruiting
- NCT06818201 — Effects of tDCS on Motor Cortex During ACL Recovery · NA · recruiting
- NCT07105657 — The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physi · recruiting
- NCT06939309 — Efficacy of Acupuncture for Shoulder Pain Based on Remote Point Selection According to the Meridians · NA · not yet recruiting
Other recruiting trials for Respiratory Distress Syndrome, Adult
Currently open trials in the same condition.
- NCT06203405 — The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Ra · NA · recruiting
- NCT04545424 — Trial of Therapeutic Hypothermia in Patients With ARDS · Phase 2 · recruiting
- NCT03368092 — Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma · Phase 3 · recruiting
- NCT03709199 — Long Term Follow up of Children Enrolled in the REDvent Study · active not recruiting
Other Universidade Metodista de Piracicaba trials
Trials by the same sponsor.
- NCT06170892 — Kangaroo Position in Preterm Newborn Infants Under Oxygen Therapy · NA · unknown
- NCT04875403 — Rehabilitation in Patients With Human Lymphotropic Virus Type I · NA · unknown
- NCT04514705 — Characteristics in Post Covid-19 Patients · NA · unknown
- NCT04513730 — Positional Device Aimed at Patients With Low Back Pain · NA · completed
- NCT03903276 — Effects of Transcutaneous Electrical Nerve Stimulation in Post-operative Lung Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03712215 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Metodista de Piracicaba
- Last refreshed: 13 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03712215.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing